Patterns of plasma levels of catechols in neurogenic orthostatic hypotension. Goldstein DS, Polinsky RJ, Garty M, Robertson D, Brown RT, Biaggioni I, Stull R, Kopin IJ (1989) Ann Neurol 26: 558-63 Prostaglandin E2-mediated attenuation of mesocortical dopaminergic pathway is critical for susceptibility to repeated social defeat stress in mice. Tanaka K, Furuyashiki T, Kitaoka S, Senzai Y, Imoto Y, Segi-Nishida E, Deguchi Y, Breyer RM, Breyer MD, Narumiya S (2012) J Neurosci 32: 4319-29 Stress and the mesocorticolimbic dopamine systems. Roth RH, Tam SY, Ida Y, Yang JX, Deutch AY (1988) Ann N Y Acad Sci 537: 138-47 The metabotropic glutamate receptor 4-positive allosteric modulator VU0364770 produces efficacy alone and in combination with L-DOPA or an adenosine 2A antagonist in preclinical rodent models of Parkinson's disease. Jones CK, Bubser M, Thompson AD, Dickerson JW, Turle-Lorenzo N, Amalric M, Blobaum AL, Bridges TM, Morrison RD, Jadhav S, Engers DW, Italiano K, Bode J, Daniels JS, Lindsley CW, Hopkins CR, Conn PJ, Niswender CM (2012) J Pharmacol Exp Ther 340: 404-21 Effects of BMY 14802, a potential antipsychotic drug, on rat brain dopaminergic function. Matthews RT, McMillen BA, Sallis R, Blair D (1986) J Pharmacol Exp Ther 239: 124-31 Effects of 6-hydroxydopamine lesions of the prefrontal cortex on tyrosine hydroxylase activity in mesolimbic and nigrostriatal dopamine systems. Rosin DL, Clark WA, Goldstein M, Roth RH, Deutch AY (1992) Neuroscience 48: 831-9 Pharmacological characterization of dopamine systems in the nucleus accumbens core and shell. Deutch AY, Cameron DS (1992) Neuroscience 46: 49-56 Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on catecholamines and metabolites in primate brain and CSF. Elsworth JD, Deutch AY, Redmond DE, Sladek JR, Roth RH (1987) Brain Res 415: 293-9 Footshock and conditioned stress increase 3,4-dihydroxyphenylacetic acid (DOPAC) in the ventral tegmental area but not substantia nigra. Deutch AY, Tam SY, Roth RH (1985) Brain Res 333: 143-6 Morphological, neurochemical, and behavioral characterizations associated with the combined treatment of diethyldithiocarbamate and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice. Yurek DM, Deutch AY, Roth RH, Sladek JR (1989) Brain Res 497: 250-9 Stress-induced alterations in neurotensin, somatostatin and corticotropin-releasing factor in mesotelencephalic dopamine system regions. Deutch AY, Bean AJ, Bissette G, Nemeroff CB, Robbins RJ, Roth RH (1987) Brain Res 417: 350-4 Regulation of the prefrontal cortical dopamine system by the neuroactive steroid 3a,21-dihydroxy-5a-pregnane-20-one. Grobin AC, Roth RH, Deutch AY (1992) Brain Res 578: 351-6 Prefrontal cortical dopamine depletion enhances the responsiveness of mesolimbic dopamine neurons to stress. Deutch AY, Clark WA, Roth RH (1990) Brain Res 521: 311-5 Neuroleptics increase striatal catecholamine metabolites but not ascorbic acid in dialyzed perfusate. Blakely RD, Wages SA, Justice JB, Herndon JG, Neill DB (1984) Brain Res 308: 1-8 Effects of (+-)3,4-methylenedioxymethamphetamine (MDMA) on brain dopaminergic activity in rats. Matthews RT, Champney TH, Frye GD (1989) Pharmacol Biochem Behav 33: 741-7 Mesolimbic and mesocortical dopamine activation induced by phencyclidine: contrasting pattern to striatal response. Deutch AY, Tam SY, Freeman AS, Bowers MB, Roth RH (1987) Eur J Pharmacol 134: 257-64 Differential responsiveness to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity in sub-regions of the primate substantia nigra and striatum. Elsworth JD, Deutch AY, Redmond DE, Sladek JR, Roth RH (1987) Life Sci 40: 193-202 Calcitonin gene-related peptide in the ventral tegmental area: selective modulation of prefrontal cortical dopamine metabolism. Deutch AY, Roth RH (1987) Neurosci Lett 74: 169-74
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.